 WESTLAKE VILLAGE, Calif., June 28, 2021 PRNewswire -- MannKind Corporation Nasdaq: MNKD appreciates the recent efforts of the Centers for Medicare and Medicaid Services CMS in conjunction with the Medicare Administration Contractors MACs to implement a policy change to the Local Coverage Determination LCD L33822, allowing the approval to Medicare patients living with diabetes to select both Afrezza and Continuous Glucose Monitors CGMs. 